Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kennerly S Patrick

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 28, 2019
Potential for Underestimation of d-Methylphenidate Bioavailability Using Chiral Derivatization/Gas ChromatographyKennerly S Patrick, Wendy Rodriguez
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 6, 2016
Absorption Differences between Immediate-Release Dexmethylphenidate and dl-MethylphenidateKennerly S Patrick, Arthur B Straughn
Journal of Clinical Psychopharmacology|June 18, 2008
Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter?John S Markowitz, Kennerly S Patrick
Journal of Child and Adolescent Psychopharmacology|September 15, 2017
The Clinical Pharmacokinetics of Amphetamines Utilized in the Treatment of Attention-Deficit/Hyperactivity DisorderJohn S Markowitz, Kennerly S Patrick
Pharmacotherapy|November 5, 2003
Advances in the pharmacotherapy of attention-deficit-hyperactivity disorder: focus on methylphenidate formulationsJohn S Markowitz, Arthur B Straughn, Kennerly S Patrick
Journal of Child and Adolescent Psychopharmacology|November 23, 2013
Isopropylphenidate: an ester homolog of methylphenidate with sustained and selective dopaminergic activity and reduced drug interaction liabilityJohn S Markowitz, Hao-Jie Zhu, Kennerly S Patrick
Journal of Pharmaceutical Sciences|October 11, 2014
Ethylphenidate as a selective dopaminergic agonist and methylphenidate-ethanol transesterification biomarkerKennerly S Patrick, Timothy R Corbin, Cristina E Murphy
Pharmacology, Biochemistry, and Behavior|September 20, 2011
Oral and transdermal DL-methylphenidate-ethanol interactions in C57BL/6J mice: potentiation of locomotor activity with oral deliveryGuinevere H Bell, William C Griffin, Kennerly S Patrick
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 16, 2011
Enantiospecific determination of DL-methylphenidate and DL-ethylphenidate in plasma by liquid chromatography-tandem mass spectrometry: application to human ethanol interactionsHao-Jie Zhu, Kennerly S Patrick, John S Markowitz
The Journal of Pharmacology and Experimental Therapeutics|February 22, 2007
Role of Ca2+-independent phospholipase A2gamma in Ca2+-induced mitochondrial permeability transitionGilbert R Kinsey, Jane McHowat, Kennerly S Patrick, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 28, 2019
Potential for Underestimation of d-Methylphenidate Bioavailability Using Chiral Derivatization/Gas ChromatographyKennerly S Patrick, Wendy Rodriguez
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 6, 2016
Absorption Differences between Immediate-Release Dexmethylphenidate and dl-MethylphenidateKennerly S Patrick, Arthur B Straughn
Journal of Clinical Psychopharmacology|June 18, 2008
Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter?John S Markowitz, Kennerly S Patrick
Journal of Child and Adolescent Psychopharmacology|September 15, 2017
The Clinical Pharmacokinetics of Amphetamines Utilized in the Treatment of Attention-Deficit/Hyperactivity DisorderJohn S Markowitz, Kennerly S Patrick
Pharmacotherapy|November 5, 2003
Advances in the pharmacotherapy of attention-deficit-hyperactivity disorder: focus on methylphenidate formulationsJohn S Markowitz, Arthur B Straughn, Kennerly S Patrick
Journal of Child and Adolescent Psychopharmacology|November 23, 2013
Isopropylphenidate: an ester homolog of methylphenidate with sustained and selective dopaminergic activity and reduced drug interaction liabilityJohn S Markowitz, Hao-Jie Zhu, Kennerly S Patrick
Journal of Pharmaceutical Sciences|October 11, 2014
Ethylphenidate as a selective dopaminergic agonist and methylphenidate-ethanol transesterification biomarkerKennerly S Patrick, Timothy R Corbin, Cristina E Murphy
Pharmacology, Biochemistry, and Behavior|September 20, 2011
Oral and transdermal DL-methylphenidate-ethanol interactions in C57BL/6J mice: potentiation of locomotor activity with oral deliveryGuinevere H Bell, William C Griffin, Kennerly S Patrick
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 16, 2011
Enantiospecific determination of DL-methylphenidate and DL-ethylphenidate in plasma by liquid chromatography-tandem mass spectrometry: application to human ethanol interactionsHao-Jie Zhu, Kennerly S Patrick, John S Markowitz
The Journal of Pharmacology and Experimental Therapeutics|February 22, 2007
Role of Ca2+-independent phospholipase A2gamma in Ca2+-induced mitochondrial permeability transitionGilbert R Kinsey, Jane McHowat, Kennerly S Patrick, et al.
Pageof 4